Loading…

Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases

We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the...

Full description

Saved in:
Bibliographic Details
Published in:European journal of obstetrics & gynecology and reproductive biology 2001-12, Vol.100 (1), p.108-111
Main Authors: Winer, Norbert, David, Albert, Leconte, Philippe, Aubron, Francoise, Rogez, Jean-Michel, Rival, Jean-Marie, Pinaud, Michel, Roze, Jean-Christophe, Boog, Georges
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 111
container_issue 1
container_start_page 108
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 100
creator Winer, Norbert
David, Albert
Leconte, Philippe
Aubron, Francoise
Rogez, Jean-Michel
Rival, Jean-Marie
Pinaud, Michel
Roze, Jean-Christophe
Boog, Georges
description We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the underskin tissues developed progressively, although the trained practitioner did not notice any particular resistance during the injection of the dye and the ultrasonographer did not point out that the foetus had been stuck by the needle. Both later reported cases concern two life threatening maternal complications due to amniocentesis for foetal karyotyping indicated by maternal age, a septic shock occurred 24 h after entering the amniotic cavity, leading to a long stay in intensive care units. In one of those cases, the patient recovered from a cardiac arrest. We come to the conclusion that the essential continuous ultrasonographic monitoring cannot avoid all complications, some of which may lead to severe adverse foetal effects and others may need an intensive medical care for the mother, mainly after iatrogenic chorioamnionitis. Experience of the perinatologist remains an important factor to limit the complications without avoiding them completely. The indications must be carefully evaluated, the information given to the patients must be clear and in the future, intraamniotic injections of dyes will have to be avoided and replaced by non-invasive tests for diagnosis of preterm premature rupture of membranes, such as diamine-oxidase, foetal fibronectin or PROM-tests. The rules of a good practice will have to be defined and widely spread.
doi_str_mv 10.1016/S0301-2115(01)00442-0
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72313512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211501004420</els_id><sourcerecordid>72313512</sourcerecordid><originalsourceid>FETCH-LOGICAL-e293t-5c4dfc580cdf40571e0129ee4054e3fb0e8b586c3306a5373150ffddc2c99edb3</originalsourceid><addsrcrecordid>eNpFkV9rFTEQxUNR2tvWj6DkRWkf1s4km_3TFymlVaEgVH0OucmkRHaTNdkV-u27t73qvJxh-HFgzmHsLcJHBGwuvoMErASiOgM8B6hrUcEB22DXiqptVP2Kbf4hR-y4lF-wjpT9ITtCbEXXtLhh91djDMlSnKmEwk103OwuIfqlhBS5W3KID3zK9BBNtI-X_J6mlGeePPdpydymcRqCNTM5bk2hcspeezMUerPXE_bz9ubH9Zfq7tvnr9dXdxWJXs6VsrXzVnVgna9BtUiAoida95qk3wJ1W9U1VkpojJKtRAXeO2eF7XtyW3nCPrz4Tjn9XqjMegzF0jCYSGkpuhUSpUKxgu_24LIdyekph9HkR_03hRV4vwdMsWbweX00lP-clB3UsDP69MLR-tafQFkXGyhaciGTnbVLQSPoXT_6uR-9C1-v-tyPBvkE0kOBPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72313512</pqid></control><display><type>article</type><title>Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases</title><source>Elsevier</source><creator>Winer, Norbert ; David, Albert ; Leconte, Philippe ; Aubron, Francoise ; Rogez, Jean-Michel ; Rival, Jean-Marie ; Pinaud, Michel ; Roze, Jean-Christophe ; Boog, Georges</creator><creatorcontrib>Winer, Norbert ; David, Albert ; Leconte, Philippe ; Aubron, Francoise ; Rogez, Jean-Michel ; Rival, Jean-Marie ; Pinaud, Michel ; Roze, Jean-Christophe ; Boog, Georges</creatorcontrib><description>We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the underskin tissues developed progressively, although the trained practitioner did not notice any particular resistance during the injection of the dye and the ultrasonographer did not point out that the foetus had been stuck by the needle. Both later reported cases concern two life threatening maternal complications due to amniocentesis for foetal karyotyping indicated by maternal age, a septic shock occurred 24 h after entering the amniotic cavity, leading to a long stay in intensive care units. In one of those cases, the patient recovered from a cardiac arrest. We come to the conclusion that the essential continuous ultrasonographic monitoring cannot avoid all complications, some of which may lead to severe adverse foetal effects and others may need an intensive medical care for the mother, mainly after iatrogenic chorioamnionitis. Experience of the perinatologist remains an important factor to limit the complications without avoiding them completely. The indications must be carefully evaluated, the information given to the patients must be clear and in the future, intraamniotic injections of dyes will have to be avoided and replaced by non-invasive tests for diagnosis of preterm premature rupture of membranes, such as diamine-oxidase, foetal fibronectin or PROM-tests. The rules of a good practice will have to be defined and widely spread.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/S0301-2115(01)00442-0</identifier><identifier>PMID: 11728671</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Amniocentesis ; Amniocentesis - adverse effects ; Amniotic Fluid ; Anti-Bacterial Agents - therapeutic use ; Biological and medical sciences ; Chorioamnionitis - etiology ; Coloring Agents - administration &amp; dosage ; Diseases of mother, fetus and pregnancy ; Dye injection ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - etiology ; Evans Blue - administration &amp; dosage ; Female ; Fetal Diseases - etiology ; Fetal Membranes, Premature Rupture - diagnosis ; Foetal complications ; Gynecology. Andrology. Obstetrics ; Humans ; Karyotyping ; Maternal Age ; Maternal complications ; Medical sciences ; Muscular Atrophy - etiology ; Oligohydramnios - diagnosis ; Pregnancy ; Pregnancy, High-Risk ; Pregnancy. Fetus. Placenta ; Shock, Septic - etiology ; Ultrasonography</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 2001-12, Vol.100 (1), p.108-111</ispartof><rights>2001 Elsevier Science Ireland Ltd</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13380402$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11728671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Winer, Norbert</creatorcontrib><creatorcontrib>David, Albert</creatorcontrib><creatorcontrib>Leconte, Philippe</creatorcontrib><creatorcontrib>Aubron, Francoise</creatorcontrib><creatorcontrib>Rogez, Jean-Michel</creatorcontrib><creatorcontrib>Rival, Jean-Marie</creatorcontrib><creatorcontrib>Pinaud, Michel</creatorcontrib><creatorcontrib>Roze, Jean-Christophe</creatorcontrib><creatorcontrib>Boog, Georges</creatorcontrib><title>Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the underskin tissues developed progressively, although the trained practitioner did not notice any particular resistance during the injection of the dye and the ultrasonographer did not point out that the foetus had been stuck by the needle. Both later reported cases concern two life threatening maternal complications due to amniocentesis for foetal karyotyping indicated by maternal age, a septic shock occurred 24 h after entering the amniotic cavity, leading to a long stay in intensive care units. In one of those cases, the patient recovered from a cardiac arrest. We come to the conclusion that the essential continuous ultrasonographic monitoring cannot avoid all complications, some of which may lead to severe adverse foetal effects and others may need an intensive medical care for the mother, mainly after iatrogenic chorioamnionitis. Experience of the perinatologist remains an important factor to limit the complications without avoiding them completely. The indications must be carefully evaluated, the information given to the patients must be clear and in the future, intraamniotic injections of dyes will have to be avoided and replaced by non-invasive tests for diagnosis of preterm premature rupture of membranes, such as diamine-oxidase, foetal fibronectin or PROM-tests. The rules of a good practice will have to be defined and widely spread.</description><subject>Adult</subject><subject>Amniocentesis</subject><subject>Amniocentesis - adverse effects</subject><subject>Amniotic Fluid</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chorioamnionitis - etiology</subject><subject>Coloring Agents - administration &amp; dosage</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Dye injection</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - etiology</subject><subject>Evans Blue - administration &amp; dosage</subject><subject>Female</subject><subject>Fetal Diseases - etiology</subject><subject>Fetal Membranes, Premature Rupture - diagnosis</subject><subject>Foetal complications</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Karyotyping</subject><subject>Maternal Age</subject><subject>Maternal complications</subject><subject>Medical sciences</subject><subject>Muscular Atrophy - etiology</subject><subject>Oligohydramnios - diagnosis</subject><subject>Pregnancy</subject><subject>Pregnancy, High-Risk</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Shock, Septic - etiology</subject><subject>Ultrasonography</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkV9rFTEQxUNR2tvWj6DkRWkf1s4km_3TFymlVaEgVH0OucmkRHaTNdkV-u27t73qvJxh-HFgzmHsLcJHBGwuvoMErASiOgM8B6hrUcEB22DXiqptVP2Kbf4hR-y4lF-wjpT9ITtCbEXXtLhh91djDMlSnKmEwk103OwuIfqlhBS5W3KID3zK9BBNtI-X_J6mlGeePPdpydymcRqCNTM5bk2hcspeezMUerPXE_bz9ubH9Zfq7tvnr9dXdxWJXs6VsrXzVnVgna9BtUiAoida95qk3wJ1W9U1VkpojJKtRAXeO2eF7XtyW3nCPrz4Tjn9XqjMegzF0jCYSGkpuhUSpUKxgu_24LIdyekph9HkR_03hRV4vwdMsWbweX00lP-clB3UsDP69MLR-tafQFkXGyhaciGTnbVLQSPoXT_6uR-9C1-v-tyPBvkE0kOBPw</recordid><startdate>20011210</startdate><enddate>20011210</enddate><creator>Winer, Norbert</creator><creator>David, Albert</creator><creator>Leconte, Philippe</creator><creator>Aubron, Francoise</creator><creator>Rogez, Jean-Michel</creator><creator>Rival, Jean-Marie</creator><creator>Pinaud, Michel</creator><creator>Roze, Jean-Christophe</creator><creator>Boog, Georges</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20011210</creationdate><title>Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases</title><author>Winer, Norbert ; David, Albert ; Leconte, Philippe ; Aubron, Francoise ; Rogez, Jean-Michel ; Rival, Jean-Marie ; Pinaud, Michel ; Roze, Jean-Christophe ; Boog, Georges</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e293t-5c4dfc580cdf40571e0129ee4054e3fb0e8b586c3306a5373150ffddc2c99edb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Amniocentesis</topic><topic>Amniocentesis - adverse effects</topic><topic>Amniotic Fluid</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chorioamnionitis - etiology</topic><topic>Coloring Agents - administration &amp; dosage</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Dye injection</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - etiology</topic><topic>Evans Blue - administration &amp; dosage</topic><topic>Female</topic><topic>Fetal Diseases - etiology</topic><topic>Fetal Membranes, Premature Rupture - diagnosis</topic><topic>Foetal complications</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Karyotyping</topic><topic>Maternal Age</topic><topic>Maternal complications</topic><topic>Medical sciences</topic><topic>Muscular Atrophy - etiology</topic><topic>Oligohydramnios - diagnosis</topic><topic>Pregnancy</topic><topic>Pregnancy, High-Risk</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Shock, Septic - etiology</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winer, Norbert</creatorcontrib><creatorcontrib>David, Albert</creatorcontrib><creatorcontrib>Leconte, Philippe</creatorcontrib><creatorcontrib>Aubron, Francoise</creatorcontrib><creatorcontrib>Rogez, Jean-Michel</creatorcontrib><creatorcontrib>Rival, Jean-Marie</creatorcontrib><creatorcontrib>Pinaud, Michel</creatorcontrib><creatorcontrib>Roze, Jean-Christophe</creatorcontrib><creatorcontrib>Boog, Georges</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winer, Norbert</au><au>David, Albert</au><au>Leconte, Philippe</au><au>Aubron, Francoise</au><au>Rogez, Jean-Michel</au><au>Rival, Jean-Marie</au><au>Pinaud, Michel</au><au>Roze, Jean-Christophe</au><au>Boog, Georges</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2001-12-10</date><risdate>2001</risdate><volume>100</volume><issue>1</issue><spage>108</spage><epage>111</epage><pages>108-111</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>We report two foetal complications after amnioinfusion with dye injection for evaluation of severe oligohydramnios in pregnancy. In the first case, an underskin colouring was to disappear within a few days. In the second case, an irreversible skin after-effect with muscular atrophy and lesion of the underskin tissues developed progressively, although the trained practitioner did not notice any particular resistance during the injection of the dye and the ultrasonographer did not point out that the foetus had been stuck by the needle. Both later reported cases concern two life threatening maternal complications due to amniocentesis for foetal karyotyping indicated by maternal age, a septic shock occurred 24 h after entering the amniotic cavity, leading to a long stay in intensive care units. In one of those cases, the patient recovered from a cardiac arrest. We come to the conclusion that the essential continuous ultrasonographic monitoring cannot avoid all complications, some of which may lead to severe adverse foetal effects and others may need an intensive medical care for the mother, mainly after iatrogenic chorioamnionitis. Experience of the perinatologist remains an important factor to limit the complications without avoiding them completely. The indications must be carefully evaluated, the information given to the patients must be clear and in the future, intraamniotic injections of dyes will have to be avoided and replaced by non-invasive tests for diagnosis of preterm premature rupture of membranes, such as diamine-oxidase, foetal fibronectin or PROM-tests. The rules of a good practice will have to be defined and widely spread.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>11728671</pmid><doi>10.1016/S0301-2115(01)00442-0</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 2001-12, Vol.100 (1), p.108-111
issn 0301-2115
1872-7654
language eng
recordid cdi_proquest_miscellaneous_72313512
source Elsevier
subjects Adult
Amniocentesis
Amniocentesis - adverse effects
Amniotic Fluid
Anti-Bacterial Agents - therapeutic use
Biological and medical sciences
Chorioamnionitis - etiology
Coloring Agents - administration & dosage
Diseases of mother, fetus and pregnancy
Dye injection
Escherichia coli Infections - drug therapy
Escherichia coli Infections - etiology
Evans Blue - administration & dosage
Female
Fetal Diseases - etiology
Fetal Membranes, Premature Rupture - diagnosis
Foetal complications
Gynecology. Andrology. Obstetrics
Humans
Karyotyping
Maternal Age
Maternal complications
Medical sciences
Muscular Atrophy - etiology
Oligohydramnios - diagnosis
Pregnancy
Pregnancy, High-Risk
Pregnancy. Fetus. Placenta
Shock, Septic - etiology
Ultrasonography
title Amniocentesis and amnioinfusion during pregnancy: Report of four complicated cases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A54%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amniocentesis%20and%20amnioinfusion%20during%20pregnancy:%20Report%20of%20four%20complicated%20cases&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Winer,%20Norbert&rft.date=2001-12-10&rft.volume=100&rft.issue=1&rft.spage=108&rft.epage=111&rft.pages=108-111&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/S0301-2115(01)00442-0&rft_dat=%3Cproquest_pubme%3E72313512%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e293t-5c4dfc580cdf40571e0129ee4054e3fb0e8b586c3306a5373150ffddc2c99edb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72313512&rft_id=info:pmid/11728671&rfr_iscdi=true